Brief: Hansa Biopharma Confidentially Submits Draft Registration Statement to U.S. SEC

Hansa Biopharma AB

08/11/2021 07:06

Nov 8 (Reuters) - Hansa Biopharma AB  HNSA.ST :
    * HANSA BIOPHARMA ANNOUNCES IT HAS CONFIDENTIALLY SUBMITTED
A
DRAFT REGISTRATION STATEMENT ON FORM F-1 TO THE U.S. SEC
RELATING TO A POTENTIAL U.S. IPO
    * DRAFT REGISTRATION STATEMENT ON TO U.S. SECURITIES AND
EXCHANGE
COMMISSION RELATING TO A POTENTIAL IPO OF AMERICAN DEPOSITARY
SHARES
    * NUMBER OF ADSS THAT MAY BE OFFERED, UNDERLYING ORDINARY
SHARES
THAT MAY BE ISSUED AND PRICE  HAVE NOT YET BEEN DETERMINED

Source text for Eikon:  ID:nWkr9jWzd8 
Further company coverage:  HNSA.ST 

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))